April 29, 2026 03:11 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
‘Nothing like playing football’: PM Modi unwinds in Sikkim after Bengal poll blitz | Crackdown on D-Company: Dawood aide Salim Dola deported to India | Mumbai horror: Man asks two security guards to recite ‘kalma’, then stabs them | ‘Fair & Lovely Babua’: TMC jabs IPS officer Ajay Pal Sharma over viral video; Akhilesh joins attack | ‘Don’t regret later’: IPS officer Ajay Pal Sharma’s warning to TMC candidate sparks BJP-TMC clash | ‘Will return for swearing-in’: Modi ends Bengal campaign, signals BJP win | Top LeT commander Sheikh Yousuf Afridi gunned down in Pakistan—Mystery gunmen strike again | 'Had a child together, now alleges rape': SC says consensual live-in breakup is not a crime | YouTuber Saleem Wastik arrested in connection with 1995 kidnapping and murder case | Maharashtra Police makes first arrest months after Akshay Kumar revealed daughter’s cyber harassment
Johnson Baby Powder
Image Credit: wikipedia.org

Maharashtra FDA cancels Johnson & Johnson baby powder licence

| @indiablooms | Sep 18, 2022, at 05:06 am

Mumbai: The Maharashtra FDA has cancelled the baby talcum powder manufacturing licence of Johnson & Johnson, Mulund, after the department found it "Not Of Standard Quality".

The FDA said that the licence was cancelled after samples of the Johnson’s Baby Powder collected from Nashik and Pune failed quality checks and ordered the company to recall all its stocks from the markets.

These samples were declared by the FDA as ‘Not Of Standard Quality’ after they failed to comply with IS5339:2009 (Second Revision Amendment No. 3) Specification for Skin Powder for infants in the test pH.

In a statement, the FDA said: “The product Johnsons Baby Powder is popularly used in newborn babies. The sample declared 'Not of Standard' in pH and the use of the product may affect the health of the skin of the newborn babies.”

The firm "didn't accept the report" and challenged it in court for sending it to the Central Drugs Laboratory, the FDA said, according to media reports.

(With UNI inputs)

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.